 Susanta Mondal
Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Encephalomyelitis, Autoimmune, Experimental | 10 | 2020 | 51 | 3.740 |
Why?
| | Multiple Sclerosis | 5 | 2020 | 91 | 1.570 |
Why?
| | T-Lymphocytes, Regulatory | 4 | 2018 | 56 | 1.450 |
Why?
| | Interleukin-12 Subunit p40 | 3 | 2020 | 20 | 1.210 |
Why?
| | Th17 Cells | 5 | 2020 | 33 | 1.190 |
Why?
| | Adoptive Transfer | 3 | 2017 | 51 | 1.120 |
Why?
| | Sodium Chloride | 2 | 2017 | 44 | 1.090 |
Why?
| | Receptors, Interleukin-12 | 2 | 2020 | 11 | 0.860 |
Why?
| | Mice | 14 | 2021 | 1894 | 0.840 |
Why?
| | Disease Models, Animal | 6 | 2021 | 832 | 0.740 |
Why?
| | Interleukin-11 | 1 | 2018 | 8 | 0.730 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 111 | 0.680 |
Why?
| | Aspirin | 1 | 2018 | 90 | 0.670 |
Why?
| | Th1 Cells | 2 | 2018 | 35 | 0.660 |
Why?
| | Animals | 15 | 2021 | 5312 | 0.660 |
Why?
| | Nebulizers and Vaporizers | 1 | 2017 | 21 | 0.640 |
Why?
| | Peptides | 2 | 2018 | 116 | 0.600 |
Why?
| | Mice, Inbred C57BL | 7 | 2020 | 548 | 0.590 |
Why?
| | Plant Extracts | 1 | 2015 | 18 | 0.560 |
Why?
| | Parkinsonian Disorders | 2 | 2019 | 210 | 0.520 |
Why?
| | Forkhead Transcription Factors | 2 | 2016 | 28 | 0.520 |
Why?
| | NF-kappa B | 2 | 2021 | 112 | 0.500 |
Why?
| | Cells, Cultured | 6 | 2021 | 802 | 0.460 |
Why?
| | Dopaminergic Neurons | 2 | 2021 | 50 | 0.390 |
Why?
| | Protein Multimerization | 1 | 2009 | 23 | 0.380 |
Why?
| | Peptide Fragments | 3 | 2018 | 122 | 0.360 |
Why?
| | Interleukin-23 | 2 | 2020 | 12 | 0.340 |
Why?
| | Interleukin-12 | 2 | 2020 | 41 | 0.330 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 301 | 0.330 |
Why?
| | Microglia | 2 | 2021 | 131 | 0.320 |
Why?
| | Cinnamomum zeylanicum | 3 | 2016 | 21 | 0.320 |
Why?
| | Female | 11 | 2020 | 18253 | 0.320 |
Why?
| | Food Preservatives | 2 | 2016 | 8 | 0.300 |
Why?
| | Sodium Benzoate | 2 | 2016 | 18 | 0.300 |
Why?
| | Blood-Brain Barrier | 2 | 2016 | 44 | 0.290 |
Why?
| | Signal Transduction | 4 | 2021 | 588 | 0.260 |
Why?
| | Oligodendroglia | 2 | 2015 | 34 | 0.260 |
Why?
| | Myelin Sheath | 2 | 2015 | 23 | 0.260 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2021 | 16 | 0.230 |
Why?
| | Toll-Like Receptor 2 | 2 | 2021 | 36 | 0.230 |
Why?
| | Recombinant Proteins | 2 | 2020 | 295 | 0.220 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2018 | 36 | 0.220 |
Why?
| | Mice, Transgenic | 3 | 2018 | 308 | 0.210 |
Why?
| | Protein Binding | 1 | 2020 | 155 | 0.200 |
Why?
| | alpha-Synuclein | 1 | 2021 | 147 | 0.190 |
Why?
| | Chemokine CCL5 | 1 | 2019 | 21 | 0.190 |
Why?
| | Myelin Proteolipid Protein | 2 | 2016 | 7 | 0.180 |
Why?
| | Gene Expression Regulation | 2 | 2012 | 351 | 0.180 |
Why?
| | Substantia Nigra | 1 | 2019 | 157 | 0.170 |
Why?
| | RNA, Messenger | 3 | 2015 | 371 | 0.170 |
Why?
| | Demyelinating Diseases | 2 | 2015 | 13 | 0.170 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 512 | 0.170 |
Why?
| | Astrocytes | 2 | 2015 | 135 | 0.160 |
Why?
| | Cell-Penetrating Peptides | 1 | 2016 | 2 | 0.160 |
Why?
| | STAT6 Transcription Factor | 1 | 2016 | 13 | 0.160 |
Why?
| | Homeodomain Proteins | 1 | 2016 | 57 | 0.150 |
Why?
| | Amino Acid Sequence | 2 | 2016 | 254 | 0.150 |
Why?
| | Ciliary Neurotrophic Factor | 1 | 2015 | 8 | 0.150 |
Why?
| | Carrier Proteins | 1 | 2016 | 129 | 0.150 |
Why?
| | Hippocampus | 1 | 2018 | 295 | 0.150 |
Why?
| | Transforming Growth Factor beta | 1 | 2016 | 126 | 0.140 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2015 | 32 | 0.140 |
Why?
| | Inflammation | 2 | 2018 | 360 | 0.140 |
Why?
| | Administration, Oral | 1 | 2015 | 164 | 0.130 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 148 | 0.130 |
Why?
| | Macrophages, Peritoneal | 1 | 2014 | 13 | 0.130 |
Why?
| | Interleukin-7 | 1 | 2014 | 25 | 0.130 |
Why?
| | Spinal Cord | 1 | 2015 | 99 | 0.130 |
Why?
| | Primary Cell Culture | 3 | 2021 | 25 | 0.130 |
Why?
| | Promoter Regions, Genetic | 3 | 2021 | 108 | 0.120 |
Why?
| | Immunoenzyme Techniques | 1 | 2012 | 54 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 60 | 0.120 |
Why?
| | PPAR-beta | 1 | 2012 | 5 | 0.120 |
Why?
| | I-kappa B Kinase | 1 | 2012 | 6 | 0.120 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 191 | 0.120 |
Why?
| | Blotting, Western | 1 | 2012 | 225 | 0.120 |
Why?
| | Flow Cytometry | 1 | 2012 | 217 | 0.120 |
Why?
| | Hypolipidemic Agents | 1 | 2012 | 28 | 0.120 |
Why?
| | Nitric Oxide | 1 | 2012 | 107 | 0.120 |
Why?
| | Macaca mulatta | 1 | 2012 | 70 | 0.120 |
Why?
| | Gemfibrozil | 1 | 2012 | 23 | 0.120 |
Why?
| | Incidence | 1 | 2015 | 829 | 0.110 |
Why?
| | Molecular Sequence Data | 1 | 2012 | 315 | 0.110 |
Why?
| | Male | 3 | 2020 | 17583 | 0.110 |
Why?
| | Nerve Tissue Proteins | 1 | 2012 | 187 | 0.110 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 230 | 0.110 |
Why?
| | Mice, Knockout | 3 | 2021 | 399 | 0.110 |
Why?
| | Cytokines | 1 | 2012 | 364 | 0.100 |
Why?
| | Up-Regulation | 3 | 2016 | 220 | 0.100 |
Why?
| | Humans | 9 | 2021 | 31481 | 0.100 |
Why?
| | Antigen Presentation | 1 | 2009 | 24 | 0.090 |
Why?
| | Myelin Basic Protein | 1 | 2009 | 17 | 0.090 |
Why?
| | Vascular Endothelial Growth Factors | 2 | 2005 | 10 | 0.090 |
Why?
| | T-Lymphocytes | 1 | 2009 | 242 | 0.080 |
Why?
| | Alzheimer Disease | 1 | 2018 | 1829 | 0.080 |
Why?
| | Brain | 1 | 2017 | 1655 | 0.080 |
Why?
| | Adult | 1 | 2020 | 9779 | 0.080 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2005 | 8 | 0.070 |
Why?
| | Disease Progression | 1 | 2009 | 861 | 0.070 |
Why?
| | Carcinoma, Renal Cell | 1 | 2005 | 46 | 0.070 |
Why?
| | Kidney Neoplasms | 1 | 2005 | 78 | 0.070 |
Why?
| | Transcription Factors | 1 | 2005 | 180 | 0.070 |
Why?
| | Pre-Eclampsia | 1 | 2003 | 8 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2003 | 6 | 0.060 |
Why?
| | Endothelium, Vascular | 1 | 2003 | 72 | 0.060 |
Why?
| | Proteinuria | 1 | 2003 | 116 | 0.060 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2021 | 29 | 0.060 |
Why?
| | Multiple System Atrophy | 1 | 2021 | 42 | 0.050 |
Why?
| | Parkinson Disease | 2 | 2021 | 1180 | 0.050 |
Why?
| | Hypertension | 1 | 2003 | 283 | 0.050 |
Why?
| | Lewy Body Disease | 1 | 2021 | 106 | 0.050 |
Why?
| | Nerve Degeneration | 1 | 2019 | 57 | 0.050 |
Why?
| | Mutation | 1 | 2021 | 464 | 0.050 |
Why?
| | Circular Dichroism | 1 | 2016 | 2 | 0.040 |
Why?
| | Antibodies, Blocking | 1 | 2016 | 9 | 0.040 |
Why?
| | Spectrometry, Fluorescence | 1 | 2016 | 15 | 0.040 |
Why?
| | Membranes, Artificial | 1 | 2016 | 12 | 0.040 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2016 | 12 | 0.040 |
Why?
| | Amyloid beta-Peptides | 1 | 2018 | 248 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2016 | 49 | 0.040 |
Why?
| | Isoquinolines | 1 | 2015 | 16 | 0.040 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2015 | 34 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2015 | 47 | 0.040 |
Why?
| | Sulfonamides | 1 | 2015 | 64 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2015 | 140 | 0.040 |
Why?
| | Interleukin-12 Subunit p35 | 1 | 2014 | 3 | 0.030 |
Why?
| | Luciferases | 1 | 2014 | 24 | 0.030 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2014 | 21 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2014 | 32 | 0.030 |
Why?
| | Transfection | 1 | 2014 | 154 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2014 | 138 | 0.030 |
Why?
| | Response Elements | 1 | 2012 | 14 | 0.030 |
Why?
| | PPAR gamma | 1 | 2012 | 16 | 0.030 |
Why?
| | RNA Stability | 1 | 2005 | 3 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2005 | 155 | 0.020 |
Why?
| | Neovascularization, Pathologic | 1 | 2005 | 68 | 0.020 |
Why?
| | Pregnancy Proteins | 1 | 2003 | 2 | 0.020 |
Why?
| | Lymphokines | 1 | 2003 | 13 | 0.020 |
Why?
| | Endothelial Growth Factors | 1 | 2003 | 8 | 0.020 |
Why?
| | Neovascularization, Physiologic | 1 | 2003 | 29 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2003 | 70 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2003 | 59 | 0.010 |
Why?
| | Pregnancy | 1 | 2003 | 457 | 0.010 |
Why?
| | Kidney | 1 | 2003 | 210 | 0.010 |
Why?
|
|
Mondal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|